Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Sulphasalazine Induced Hepatotoxicity, A Risk factor of Meconium Aspiration Syndrome in Neonates:A Case Study


Affiliations
1 Department of Pharmacology, Nirmala College of Pharmacy, Mangalagiri, Guntur, Andhra Pradesh, India
     

   Subscribe/Renew Journal


Meconium aspiration syndrome (MAS) may be defined as a respiratory distress which develops due to the aspiration of meconium (first feces of newborn infant). It remains as one of the most common causes of neonatal respiratory distress. Among the maternal complication Maternal Hepatitis was most common 2(3.5%) which was supported in another study by Vineeta Gupta, B.D. Bhatia and O.P. Mishra (1996) in BHU showed of the various antenatal complications studied, where only hepatitis was significantly associated with Meconium aspiration syndrome.[2] In this case a pregnant woman suffering with high grade fever with chills and arthralgia was treated with sulphasalazine for 5 days then the liver parameters were elevated in her due to sulphaselazine hepatotoxicity, it further lead to the development of meconium aspiration syndrome in newborn baby. So the treatment with sulphasalazine was discontinued and the hepatotoxicity was treated with liver protectants. In this case as a clinical pharmacist our main intervention is to avoid the use of sulphasalazine in pregnant women.

Keywords

Sulphasalazine Hepatotoxicity, Meconium Aspiration Syndrome, Maternal Hepatitis, Respiratory Distress and Rheumatoid Arthritis.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Jobanputra P. et al. Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: a case series from a local surveillance of serious adverse events. BMC Musculoskeletal Disorder. 2008; 9: 48.
  • Gupta V, Bhatia BD, Mishra OP. Meconium stained amniotic fluid antenatal intrapartum and neonatal attributes. Ind Pediatr 1996; 33:293-297
  • Ashtekar SD, et al. Clinical study of meconium aspiration syndrome in relation to birth weight and gestational maturity at general hospital Sangli. Med Pulse Int Med J. 2014; 1(5):189-92.
  • Unnisa S, et al. Maternal and fetal out come in meconium stained amniotic fluid in a tertiary center. Int J Reprod Contracept Obstet Gynecol. 2016; 5(3):813- 17.
  • Ross MG. Meconium aspiration syndrome – more than intrapartum meconium. N Engl J Med. 2005; 353(9):946-48.
  • Wiswell TE, Bent RC. Meconium staining and the meconium aspiration syndrome: unresolved issues. Pediatric Clin North Am. 1993; 40(5):955-81.
  • Nath GDR et al, Study of clinical profile of meconium aspiration syndrome in relation to gestational age and birth weight and their immediate outcome at Narayana Medical College Hospital, Nellore, India International Journal of Contemporary Pediatrics, 2017 Nov;4(6):2142-2150
  • S. C. Blackwell, et al., “Meconium aspiration syndrome in term neonates with normal acid-base status at delivery: is it different?” American Journal of Obstetrics &Gynecology, vol. 184, no. 7, pp. 1422–1426, 2001.
  • A. Ghidini and C. Y. Spong, “Severe meconium aspiration syndrome is not caused by aspiration of meconium,” American Journal of Obstetrics Gynecology, vol. 185, no. 4, pp. 931–938, 2001.
  • Kamala Swarnam et al, Advances in the Management of Meconium Aspiration Syndrome, International Journal of Pediatrics Volume 2012, Article ID 359571, 7 pages doi:10.1155/2012/359571
  • Sarika Sukesh Nair. Clinical Management of Amniotic Fluid Embolism. Asian J. Nur. Edu. and Research.2017; 7(1): 120-122.
  • Do-Jin Kim, Jong-Hyuck Kim. Relationship between Cardiopulmonary function Metabolic Syndrome Indices. Research J. Pharm. and Tech 2017; 10 (11): 3868-3872.
  • P. Maheshwari, I. Somasundaram. Health Related Quality of Life Measurement in Asthma and Chronic Obstructive Pulmonary Disease. Research J. Pharm. and Tech. 2016; 9(5): 518-520.
  • R. R. Shah, M. S. Kondawar, S. S. Shinde, N. D. Shah. Formulation and Evaluation of Spray-dried Combination Respirable Powder Based on Selection of Excipients for Pulmonary Delivery: Comparison between Lactose and Mannitol. Research J. Pharm. and Tech. 4(10): Oct. 2011; Page 1604-1614.
  • Sarika Sukesh Nair. Clinical Management of Amniotic Fluid Embolism. Asian J. Nur. Edu. and Research.2017; 7(1): 120-122.
  • Wal Pranay, Wal Ankita, Srivastava Rishabh, Rastogi Prateek, Rai Awani K. Antibiotic Therapy in Pediatric Patients. Research J. Pharm. and Tech. 3(1): Jan.-Mar. 2010; Page 118-120.
  • R. Malathi S. Ahamed John, A. Cholarajan. Tylophora asthmatica L. Prevents Lipid Peroxidation in Acetaminophen Induced Hepato Toxicity in Rats. Asian J. Res. Pharm. Sci. 1(3): July-Sept. 2011; Page 71-73.
  • P, Karthikeyan.J. Modulation of Antioxidant Potential in Liver of Albino rats by seeds of Nelumbo nucifera Gaertn. in 1,4 Dichlorobenzene induced hepato toxicity. Research J. Pharm. and Tech. 5(4): April 2012; Page 538-540.
  • S. R Peter. An exploratory study to assess the level of satisfaction of post natal mothers regarding the nursing care given to their neonates in a selected hospital Dhamtari (CG). Asian J. Nur. Edu. and Research 3(2): April.- June 2013; Page 122-123.
  • K. V Shyamala, V. Ravichandra, N. K. Subbalakshmi, R. Sheila Pai, K. Raghuveera. Iron Status Indicators of Neonates of Mild to Moderate Anaemic Mothers. Research J. Pharm. and Tech. 5(2): Feb. 2012; Page 203-206.

Abstract Views: 232

PDF Views: 0




  • Sulphasalazine Induced Hepatotoxicity, A Risk factor of Meconium Aspiration Syndrome in Neonates:A Case Study

Abstract Views: 232  |  PDF Views: 0

Authors

SK. Mohammed Firdoz
Department of Pharmacology, Nirmala College of Pharmacy, Mangalagiri, Guntur, Andhra Pradesh, India
T. Vinay Kumar
Department of Pharmacology, Nirmala College of Pharmacy, Mangalagiri, Guntur, Andhra Pradesh, India
P. Divya Jyothi
Department of Pharmacology, Nirmala College of Pharmacy, Mangalagiri, Guntur, Andhra Pradesh, India
Undrakonda Ajay
Department of Pharmacology, Nirmala College of Pharmacy, Mangalagiri, Guntur, Andhra Pradesh, India
G. V. Naveen Kumar
Department of Pharmacology, Nirmala College of Pharmacy, Mangalagiri, Guntur, Andhra Pradesh, India
K. Paul Pratheek
Department of Pharmacology, Nirmala College of Pharmacy, Mangalagiri, Guntur, Andhra Pradesh, India

Abstract


Meconium aspiration syndrome (MAS) may be defined as a respiratory distress which develops due to the aspiration of meconium (first feces of newborn infant). It remains as one of the most common causes of neonatal respiratory distress. Among the maternal complication Maternal Hepatitis was most common 2(3.5%) which was supported in another study by Vineeta Gupta, B.D. Bhatia and O.P. Mishra (1996) in BHU showed of the various antenatal complications studied, where only hepatitis was significantly associated with Meconium aspiration syndrome.[2] In this case a pregnant woman suffering with high grade fever with chills and arthralgia was treated with sulphasalazine for 5 days then the liver parameters were elevated in her due to sulphaselazine hepatotoxicity, it further lead to the development of meconium aspiration syndrome in newborn baby. So the treatment with sulphasalazine was discontinued and the hepatotoxicity was treated with liver protectants. In this case as a clinical pharmacist our main intervention is to avoid the use of sulphasalazine in pregnant women.

Keywords


Sulphasalazine Hepatotoxicity, Meconium Aspiration Syndrome, Maternal Hepatitis, Respiratory Distress and Rheumatoid Arthritis.

References